Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/23 17:50 | 5/9/23 | FDMT | Health | BioPrd | Biological Products, (No Diag | Viking Global Investors LP | CT | T | P | 13,600 | 16.00 | 0 | 850 | 22 | 4,788 | I | |||||||||||||||
12/17/20 21:15 | 12/15/20 | FDMT | Health | BioPrd | Biological Products, (No Diag | Viking Global Investors LP | CT | T | P.d | 25,300 | 23.00 | 0 | 1,100 | 39 | 3,938 | I | |||||||||||||||
12/17/20 17:40 | 12/15/20 | FDMT | Health | BioPrd | Biological Products, (No Diag | Milligan John F | CA | D | P | 2,300 | 23.00 | 0 | 100 | New | 100 | I | |||||||||||||||
12/17/20 17:40 | 12/15/20 | FDMT | Health | BioPrd | Biological Products, (No Diag | Kamal Fariborz | CA | O | See Rema | P | 100 | 23.00 | 0 | 4 | New | 4 | D | ||||||||||||||
12/17/20 17:39 | 12/15/20 | FDMT | Health | BioPrd | Biological Products, (No Diag | Yao Tony Dung Ling | CA | D | P.d | 9,775 | 23.00 | 0 | 425 | 67 | 1,064 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |